urotensin receptor

[Orn5]-URP acetate 是一种有效的选择性 Urotensin-II receptor (UT) 拮抗剂 (pEC50 = 7.24)。 [Orn5]-URP 没有激动剂活性。

Urotensin II, mouse acetate (9047-55-6 free base) 是孤儿 GPR14 或 SENR 的内源性配体。它是一种强效血管收缩剂。

Urotensin II (114-124), human acetate(251293-28-4 free base) 是一种 11 个氨基酸残基肽，是一种有效的血管收缩剂和孤儿受体 GPR14 的激动剂。

UFP 803 acetate 是一种有效的 urotensin-II (UT) 受体配体。 UFP-803 显示较低残留激动剂的活性。

Urantide acetate(669089-53-6 free base) 是一种选择性和竞争性的 urotensin-II (UT) 受体拮抗剂 (pKB = 8.3)。体外阻断 hU-II 诱导的胸主动脉收缩。对去甲肾上腺素或内皮素 1 诱导的收缩或乙酰胆碱诱导的松弛没有影响。在钙动员测定（在表达 hUT 受体的 CHO 细胞中）中表现为部分激动剂。

[Lys8, Lys9]-Neurotensin (8-13) (JMV438) is a Neurotensin analog that elicits analgesic effects by activating the G protein-coupled receptors NTS1 and NTS2. The compound has K i values of 0.33 nM and 0.95 nM for hNTS1 and hNTS2 receptors, respectively.

[D-Trp11]-Neurotensin is a compound that functions as a selective antagonist of Neurotensin (NT) in perfused rat hearts, while exhibiting full agonist properties in guinea pig atria and rat stomach strips. Additionally, this compound can inhibit hypotension induced by NT.

Contulakin G为O-糖基化无脊椎动物神经紧张素，作为较弱的神经紧张素受体(neurotensin receptor)激动剂，并具有有效的镇痛作用。

Neurotensin(8-13) 是神经降压素的活性片段，可导致细胞表面 NT1 受体 (NTR1) 密度降低。

Acetyl neurotensin (8-13) 是神经降压素类似物，具有完全结合和药理活性。

hNTS1R agonist-1 (Compound 10)为能穿透血脑屏障的hNTS1R全激动剂（Ki：6.9 nM）。它能提升帕金森病（PD）模型小鼠的运动能力及记忆。作为一种Neurotensin(8-13)类似物，hNTS1R agonist-1同时具有神经保护作用。

Kinetensin is a neurotensin-like peptide.

Neurotensin 是一种 13 个氨基酸的神经肽，参与调节促黄体激素和催乳素的释放，并与多巴胺能系统有显着的相互作用。它作为细胞有丝分裂原，作用于各种结肠直肠癌和胰腺癌。

Potent, metabolically stable neurotensin receptor agonist peptide (IC50 = 0.15 nM for inhibition of [125I]-NT binding to neonatal mouse brain; EC50 = 1.9 nM for contraction of guinea pig ileum). Produces long-lasting hypothermic, neuroprotective and analg

Urotensin I acetate 是一种 CRF 样神经肽，可作为 CRF 受体激动剂，对 CHO 细胞中的人 CRF1、人 CRF2 和大鼠 CRF2α 受体的 pEC50 分别为 11.46、9.36 和 9.85，对 CHO 细胞的 Kis 分别为 0.4、1.8 和 5.7 nM hCRF1、rCRF2α 和 mCRF2β 受体。

Selective and competitive urotensin-II (UT) receptor antagonist (pKB = 8.3). Blocks hU-II induced contractions in thoracic aorta ex vivo. Exhibits no effect on noradrenaline or endothelin 1-induced contraction or on acetylcholine-induced relaxation. Behav

Urocortin III is a neuropeptide hormone and member of the corticotropin-releasing factor (CRF) family which includes mammalian CRF , urocortin , urocortin II , frog sauvagine, and piscine urotensin I.1 Human urocortin III shares 90, 40, 37, and 21% identity to mouse urocortin III , mouse urocortin II , human urocortin , and mouse urocortin, respectively. Urocortin III selectively binds to type 2 CRF receptors (Kis = 21.7, 13.5, and >100 nM for rat CRF2α, rat CRF2β, and human CRF1, respectively). It stimulates cAMP production in CHO cells expressing rat CRF2α and mouse CRF2β (EC50s = 0.16 and 0.12 nM, respectively) as well as cultured anterior pituitary cells expressing endogenous CRF2β. Urocortin III is co-released with insulin to potentiate glucose-stimulated somatostatin release in vitro in human pancreatic β-cells.2 In vivo, urocortin III reduces food intake in a dose- and time-dependent manner in mice with a minimum effective dose (MED) of 0.3 nmol/animal.3 It increases swimming time in a forced swim test in mice, indicating antidepressant-like activity.4References1. Lewis, K., Li, C., Perrin, M.H., et al. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc. Natl. Acad. Sci. U.S.A. 98(13), 7570-7575 (2001).2. van der Meulen, T., Donaldson, C.J., Cáceres, E., et al. Urocortin3 mediates somatostatin-dependent negative feedback control of insulin secretion. Nat. Med. 21(7), 769-776 (2015).3. Pelleymounter, M.A., Joppa, M., Ling, N., et al. Behavioral and neuroendocrine effects of the selective CRF2 receptor agonists urocortin II and urocortin III. Peptides 25(4), 659-666 (2004).4. Tanaka, M., Kádár, K., Tóth, G., et al. Antidepressant-like effects of urocortin 3 fragments. Brain Res. Bull. 84(6), 414-418 (2011). Urocortin III is a neuropeptide hormone and member of the corticotropin-releasing factor (CRF) family which includes mammalian CRF , urocortin , urocortin II , frog sauvagine, and piscine urotensin I.1 Human urocortin III shares 90, 40, 37, and 21% identity to mouse urocortin III , mouse urocortin II , human urocortin , and mouse urocortin, respectively. Urocortin III selectively binds to type 2 CRF receptors (Kis = 21.7, 13.5, and >100 nM for rat CRF2α, rat CRF2β, and human CRF1, respectively). It stimulates cAMP production in CHO cells expressing rat CRF2α and mouse CRF2β (EC50s = 0.16 and 0.12 nM, respectively) as well as cultured anterior pituitary cells expressing endogenous CRF2β. Urocortin III is co-released with insulin to potentiate glucose-stimulated somatostatin release in vitro in human pancreatic β-cells.2 In vivo, urocortin III reduces food intake in a dose- and time-dependent manner in mice with a minimum effective dose (MED) of 0.3 nmol/animal.3 It increases swimming time in a forced swim test in mice, indicating antidepressant-like activity.4 References1. Lewis, K., Li, C., Perrin, M.H., et al. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc. Natl. Acad. Sci. U.S.A. 98(13), 7570-7575 (2001).2. van der Meulen, T., Donaldson, C.J., Cáceres, E., et al. Urocortin3 mediates somatostatin-dependent negative feedback control of insulin secretion. Nat. Med. 21(7), 769-776 (2015).3. Pelleymounter, M.A., Joppa, M., Ling, N., et al. Behavioral and neuroendocrine effects of the selective CRF2 receptor agonists urocortin II and urocortin III. Peptides 25(4), 659-666 (2004).4. Tanaka, M., Kádár, K., Tóth, G., et al. Antidepressant-like effects of urocortin 3 fragments. Brain Res. Bull. 84(6), 414-418 (2011).

Urotensin II-related peptide acetate 是G蛋白偶联受体 GPR14（现称 UT）的内源性配体。Urotensin II 与 URP 可在外周组织（包括心血管系统、气道平滑肌、肾脏及内分泌腺）中发挥多种生物学作用，其在中枢系统给药后亦可诱导复杂的行为及心血管反应，凸显其生理与药理学重要性。

[Orn8]-Urotensin II 是一种 Urotensin 受体配体和 Urotensin 受体的部分激动剂。

[Orn8]-Urotensin II acetate 是一种 Urotensin 受体配体和 Urotensin 受体的部分激动剂。

UFP-803 TFA 是有效的urotensin-II receptor (UT)配体。UFP-803 TFA 具有较低的残留激动剂活性，因此它可以作为研究UT 系统在生理学和病理学中作用的重要工具。

[Orn5]-URP TFA 为Urotensin-II receptor (UT) 的有效且选择性纯拮抗剂，具pEC50值7.24，未呈现激动剂活性。

Urotensin II, mouse acetate，是孤儿G蛋白偶联受体（GPR14或SENR）的一种内源性配体，具有显著的血管收缩活性并在中枢神经系统中发挥重要功能。

Urotensin I is, 41-aa neuropeptide, acts as an agonist of CRF receptor with pEC50s of 11.46, 9.36 and 9.85 for human CRF1, human CRF2 and rat CRF2α receptors in CHO cells, and Kis of 0.4, 1.8, and 5.7 nM for hCRF1, rCRF2α and mCRF2β receptors, respectivel